Advertisements
Pasireotide
| Price: | US$ 2000 / Gram |
|---|---|
| Minimum Order: | 1g |
| Payment Terms: | T/T |
| Port of Export: | Hangzhou |
Product Details
| Model No.: | 396091-73-9 | Brand Name: | ZPC |
|---|
| Certification: | ISO9001; DMF |
|---|---|
| Specification: |
Full Name：Pasireotide/p>
Cas No：396091-73-9 Molecular Formular: C58H66N10O9 Molecular Weight: 1047.21 Sequence：Cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl] Purity：≥98.0% |
Packaging & Delivery
| Packaging: | 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. |
|---|---|
| Delivery/Lead Time: | 2-4 weeks |
| Production Capacity: | 100000kg |
Product Description
Pasireotide (SOM230, trade name Signifor) is an orphan drug approved in the United States and Europe for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs.
|
SUPPLIER PROFILE
|
|||
|---|---|---|---|
| Company: | Zhejiang Peptites Biotech Co., Ltd | ||
| City/State | Hangzhou, Zhejiang | Country: |
China 
|
| Business Type: | Export - Manufacturer / Trading Company | Established: | 2014 |
| Member Since: | 2017 | Contact Person | Zoe Chen |
SUPPLIER PROFILE
City/State/Country -
Hangzhou, Zhejiang
China
Business Type -
Export - Manufacturer / Trading Company
Established -
2014
Member Since -
2017
Contact Person -
Zoe Chen